IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer

Background: Interleukin (IL)-23 and IL-27 are two IL-12-related cytokines which their function may dramatically influence the inflammatory response to tumor development. IL-12 and IL-27 seem to have antagonistic roles with IL-23 in tumor site. In this study, IL-23 and IL-27 mRNA expressions were ana...

Full description

Bibliographic Details
Main Authors: Ali Khodadadi, Mahboobeh Razmkhah, Ali-Reza Eskandari, Ahmad Hosseini, Mojtaba Habibagahi, bbas Ghaderi, Mansooreh Jaberipour
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2014-07-01
Series:Iranian Journal of Medical Sciences
Subjects:
Online Access:http://ijms.sums.ac.ir/index.php/IJMS/article/view/949
_version_ 1818178821427298304
author Ali Khodadadi
Mahboobeh Razmkhah
Ali-Reza Eskandari
Ahmad Hosseini
Mojtaba Habibagahi
bbas Ghaderi
Mansooreh Jaberipour
author_facet Ali Khodadadi
Mahboobeh Razmkhah
Ali-Reza Eskandari
Ahmad Hosseini
Mojtaba Habibagahi
bbas Ghaderi
Mansooreh Jaberipour
author_sort Ali Khodadadi
collection DOAJ
description Background: Interleukin (IL)-23 and IL-27 are two IL-12-related cytokines which their function may dramatically influence the inflammatory response to tumor development. IL-12 and IL-27 seem to have antagonistic roles with IL-23 in tumor site. In this study, IL-23 and IL-27 mRNA expressions were analyzed in peripheral blood of patients with breast cancer and healthy volunteers using quantitative real-time PCR. Methods: Peripheral blood samples were collected from 50 women with breast cancer and 50 healthy ones. The total RNA was extracted from peripheral blood after lysis with ammonium chloride and TRizol reagent and the cDNA was synthesized. The expression of IL-23 and IL-27 gene transcripts was determined with real-time polymerase chain reaction (qRT-PCR) using Syber Green PCR Master Mix. Results: It is found that IL-23 and IL-27 transcripts had significantly higher expression in peripheral blood of patients compared with the healthy controls. The ratio of IL-23 transcript expression to IL-27 was 3.4 fold lower in the studied patients compared with the normal individuals. Conclusion: It is concluded that the over expression of IL-23 and IL-27 gene transcript in peripheral blood of breast cancer patients may be an immune response against tumor development and the inflammatory response plays a critical role in tumor development via up regulating the corresponding cytokines. However, the IL-23/IL-27 ratio may play an important role in cytokine-based immunotherapy against cancer. Further research should be carried out to assess these cytokines in a larger sample size.
first_indexed 2024-12-11T20:54:04Z
format Article
id doaj.art-b4ba8080719d4c51af012ea13f0f68b3
institution Directory Open Access Journal
issn 0253-0716
1735-3688
language English
last_indexed 2024-12-11T20:54:04Z
publishDate 2014-07-01
publisher Shiraz University of Medical Sciences
record_format Article
series Iranian Journal of Medical Sciences
spelling doaj.art-b4ba8080719d4c51af012ea13f0f68b32022-12-22T00:51:10ZengShiraz University of Medical SciencesIranian Journal of Medical Sciences0253-07161735-36882014-07-01394350356IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast CancerAli Khodadadi0Mahboobeh Razmkhah1Ali-Reza Eskandari2Ahmad Hosseini3Mojtaba Habibagahi4bbas Ghaderi5Mansooreh Jaberipour6Department of Immunology, Ahvaz Jondishapur University of Medical Sciences, Ahvaz, Iran;Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;Department of Immunology, Ahvaz Jondishapur University of Medical Sciences, Ahvaz, Iran;Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;Background: Interleukin (IL)-23 and IL-27 are two IL-12-related cytokines which their function may dramatically influence the inflammatory response to tumor development. IL-12 and IL-27 seem to have antagonistic roles with IL-23 in tumor site. In this study, IL-23 and IL-27 mRNA expressions were analyzed in peripheral blood of patients with breast cancer and healthy volunteers using quantitative real-time PCR. Methods: Peripheral blood samples were collected from 50 women with breast cancer and 50 healthy ones. The total RNA was extracted from peripheral blood after lysis with ammonium chloride and TRizol reagent and the cDNA was synthesized. The expression of IL-23 and IL-27 gene transcripts was determined with real-time polymerase chain reaction (qRT-PCR) using Syber Green PCR Master Mix. Results: It is found that IL-23 and IL-27 transcripts had significantly higher expression in peripheral blood of patients compared with the healthy controls. The ratio of IL-23 transcript expression to IL-27 was 3.4 fold lower in the studied patients compared with the normal individuals. Conclusion: It is concluded that the over expression of IL-23 and IL-27 gene transcript in peripheral blood of breast cancer patients may be an immune response against tumor development and the inflammatory response plays a critical role in tumor development via up regulating the corresponding cytokines. However, the IL-23/IL-27 ratio may play an important role in cytokine-based immunotherapy against cancer. Further research should be carried out to assess these cytokines in a larger sample size.http://ijms.sums.ac.ir/index.php/IJMS/article/view/949NeoplasmsBreast NeoplasmInterleukin-23Interleukin-27
spellingShingle Ali Khodadadi
Mahboobeh Razmkhah
Ali-Reza Eskandari
Ahmad Hosseini
Mojtaba Habibagahi
bbas Ghaderi
Mansooreh Jaberipour
IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
Iranian Journal of Medical Sciences
Neoplasms
Breast Neoplasm
Interleukin-23
Interleukin-27
title IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
title_full IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
title_fullStr IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
title_full_unstemmed IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
title_short IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
title_sort il 23 il 27 ratio in peripheral blood of patients with breast cancer
topic Neoplasms
Breast Neoplasm
Interleukin-23
Interleukin-27
url http://ijms.sums.ac.ir/index.php/IJMS/article/view/949
work_keys_str_mv AT alikhodadadi il23il27ratioinperipheralbloodofpatientswithbreastcancer
AT mahboobehrazmkhah il23il27ratioinperipheralbloodofpatientswithbreastcancer
AT alirezaeskandari il23il27ratioinperipheralbloodofpatientswithbreastcancer
AT ahmadhosseini il23il27ratioinperipheralbloodofpatientswithbreastcancer
AT mojtabahabibagahi il23il27ratioinperipheralbloodofpatientswithbreastcancer
AT bbasghaderi il23il27ratioinperipheralbloodofpatientswithbreastcancer
AT mansoorehjaberipour il23il27ratioinperipheralbloodofpatientswithbreastcancer